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ABSTRACT
To understand the molecular mechanisms that
underlie global transcriptional regulation, it is es-
sential to first identify all the transcriptional regula-
tory elements in the human genome. The advent
of next-generation sequencing has provided a
powerful platform for genome-wide analysis of dif-
ferent species and specific cell types; when
combined with traditional techniques to identify
regions of open chromatin [DNaseI hypersensitivity
(DHS)] or specific binding locations of transcription
factors [chromatin immunoprecipitation (ChIP)], and
expression data from microarrays, we become
uniquely poised to uncover the mysteries of the
genome and its regulation. To this end, we have per-
formed global meta-analysis of the relationship
among data from DNaseI-seq, ChIP-seq and expres-
sion arrays, and found that specific correlations
exist among regulatory elements and gene expres-
sion across different cell types. These correlations
revealed four distinct modes of chromatin domain
structure reflecting different functions: repressive,
active, primed and bivalent. Furthermore, CCCTC
-binding factor (CTCF) binding sites were identified
based on these integrative data. Our findings un-
covered a complex regulatory process involving by
DNaseI HS sites and histone modifications, and
suggest that these dynamic elements may be re-
sponsible for maintaining chromatin structure and
integrity of the human genome. Our integrative
approach provides an example by which data from
diverse technology platforms may be integrated to
provide more meaningful insights into global tran-
scriptional regulation.
INTRODUCTION
Consistent proper function of all biologic processes relies
on the precise spatial and temporal expression of genes
(1–3). Development, differentiation, proliferation, apop-
tosis, and even aging, are the culmination of cell
type-speciﬁc and ubiquitous gene expression. Since tran-
scription was ﬁrst described researchers have sought to
deﬁne the molecular mechanisms that regulate this phe-
nomenon, driven by the belief that understanding the gene
expression proﬁles of normal and disease states will facili-
tate discoveries of therapeutic targets to alleviate human
and animal suffering. These works have deﬁned several
types of cis-acting transcriptional regulators, including
promoters, enhancers, insulators and locus control
regions (LCR) (1,4,5) and the trans-acting factors that
bind to them. Nonetheless, the relative roles of these regu-
latory DNA elements have yet to be fully elucidated. The
introduction of high-throughput sequencing (6) and its
massive amounts of data spanning entire genomes of
species has provided a platform from which we may
begin to examine global patterns of gene expression and
compare these patterns among different cell types to gain
a clearer understanding of the molecular mechanisms
underlying the dynamic and complex processes of life.
Next-generation sequencing (NGS) has become a
popular approach to identifying gene regulatory elements
and to performing accurate functional analysis (6). NGS
of DNA–protein complexes isolated by chromatin
immunoprecipitation, a procedure known as (ChIP-seq),
has allowed for global localization of regulatory elements
associated with a speciﬁc protein of interest (7–11).
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to known (previously characterized) trans-acting factors
and is limited by its requirement for a high quality
ChIP-grade antibody to isolate the transcription factor
(TF) to be analyzed (9). By coupling the NGS method
with DNaseI hypersensitive (DNaseI HS) site mapping
(long considered the gold-standard for comprehensively
identifying the location of various classes of transcrip-
tional regulatory elements), a particularly powerful high-
resolution procedure, DNase-seq, was developed (12–18).
Like the ChIP-seq procedure, though, DNase-seq suffers
from some inherent limitations. DNase-seq provides only
location data and is unable to directly characterize
function or identify the particular TF(s) associated with
the region.
The data obtained from each of these combined-NGS
procedures may be analyzed in parallel (along with data
obtained from gene expression arrays) to facilitate the
identiﬁcation of bona ﬁde transcriptional regulatory
elements. First, though, we must obtain a thorough under-
standing of the different types of cis-regulatory sequence
elements and epigenetic modulatory mechanisms in order
to accurately investigate their contributions to spatial and
temporal gene expression.
The ﬁrst genome-wide maps of histone methylation (7)
and acetylation marks (19) were generated from human
resting CD4
+ T cells. Histone modiﬁcations associated
with gene transcription were designated as active, while
those associated with repressed transcription were desig-
nated as repressive. Intriguingly, some of the ‘active’ were
identiﬁed in transcriptionally silent genes (7,20–23), sug-
gesting that these modiﬁcations may act more as markers
of genes primed for transcriptional activity. Not surpris-
ingly, then, histone modiﬁcation is not the sole mediator
of expression level (24). By performing DNase-seq and
DNase fragment, hybridization to microarray chip
(DNase-chip), Boyle et al. (25) created a comprehensive
genome-wide map of the open chromatin regions in CD4
+
T cells. Their analysis of the resultant data sets did not
identify a clear correlation between DNaseI HS and levels
of gene expression. Shortly thereafter, Xi et al. (26) used
DNase-chip to comparatively analyze six human cell types
in order to identify functional cell type speciﬁc and ubi-
quitous DNaseI HS sites (DHSs). Their examination of
1% of the human genome revealed that cell type-speciﬁc
DNaseI HS sites co-localized with cell type-speciﬁc gene
expression. Recently, Stitzel et al. (27) conducted genome-
wide analysis of DNaseI hypersensitive sites in human
islets. Ling et al. (28) produced a set of detailed, high-
quality, genome-wide DNaseI hypersensitivity maps in
the mouse liver in vivo. These studies highlight the utility
of DNase-seq for systematically uncovering cis-regulatory
elements on a genome-wide scale.
In the study presented herein, we performed a genome-
wide meta-analysis of DNaseI HS sites identiﬁed in 29
different cell types. We sought to determine the relation-
ship between DNaseI HS, histone modiﬁcations and gene
expression. We found that speciﬁc correlations exist
between DNaseI HS, gene expression and the amounts
of active and repressive histone modiﬁcations across dif-
ferent cell types. These correlations displayed four distinct
modes (repressive, active, bivalent and primed), reﬂecting
different functions of the chromatin domains.
Furthermore, CCCTC binding factor (CTCF) binding
sites were newly identiﬁed based on these integrative
data. Our ﬁndings revealed a situation of complex regula-
tion of gene expression mediated by DNaseI hypersensi-
tive chromatin regions and their histone modiﬁcations.
MATERIALS AND METHODS
DNase-seq, ChIP-seq, gene expression and Gencode data
All data used in this study were freely available for down-
load from the University of California, Santa Cruz
(UCSC) NCBI36/hg18 Genome Browser (http://genome
.ucsc.edu/encode/) (29,30). The Open Chromatin (25)
track was used to obtain DNase-seq data from 29 cell
lines and ChIP-seq data of CTCF, c-Myc and RNA Pol
II. The Broad Histone (22) track provided the ChIP-seq
data of histone modiﬁcations from nine cell lines. Regions
of enriched signal in either DNaseI HS or ChIP experi-
ments were identiﬁed using F-Seq (31). The gene annota-
tions presented herein were taken from the Gencode data
(32) in the Gencode Genes track (Version 3c, October
2009). The detailed information of these data was pre-
sented in Supplementary Table S1. Finally, the 17 751
UCSC known human genes with expression data were
obtained from the Gene Expression Omnibus database
(series GSE15805 and GSE17793; http://www.ncbi.nlm.
nih.gov/projects/geo/). All chromosome Y data were
omitted from this study.
Classiﬁcation of DNaseI HS sites relative to cell types
Considering the lineage speciﬁcity observed with DNaseI
HS sites (Supplementary Figure S1) (26), we classiﬁed
DNaseI HS sites according to their occurrence rates in
29 cell lines. A given DNaseI HS site is classiﬁed as cell
type speciﬁc, if it does not overlap (Here, overlap between
two binding sites represents that these two regions have at
least one common base pair.) with any DNaseI HS site
within other 28 cell lines. A given DNaseI HS site is clas-
siﬁed ubiquitous, if it overlaps with any DNaseI HS site
within all 28 cell lines. The remaining DNaseI HS sites are
classiﬁed as common, which are present in two to 28 cell
lines. The results showed that about one-half of DNaseI
HS sites were found in two cell lines (Supplementary
Table S2). The cell lines that had the highest DNaseI
HS overlap (74.96%) were the two lymphocyte lines,
GM12891 and GM12892; the lowest overlap (25.99%)
was found between AoSMC (aortic smooth muscle) and
Medullo (Medulloblastoma). This agreed with the cluster-
ing analysis that we performed on DNaseI HS sites
(Supplementary Figure S1).
Tag density proﬁles
The proﬁles of tag density at DNaseI HS sites or at tran-
scription start sites (TSSs) were generated as described by
Wang et al. (19). Brieﬂy, the DNaseI HS region was
examined in 200bp windows that spanned the 5kb imme-
diately upstream of the DNaseI HS start site (dxStart) and
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(dxEnd); each window was evaluated for content of
uniquely mapped ChIP-seq data of histone modiﬁcations
and TFs. The DNaseI HS site itself was divided equally
among 10 windows for detailed analysis. All window tag
counts were normalized to the total number of bases
present in the window and to the total read number of
the given library.
To plot the proﬁles of those DNaseI HSs associated
with TSSs, the 17 751 UCSC known genes with expression
information were categorized among broad groups ac-
cording to their reported expression levels: high, median
or mainly silent. One thousand genes were selected per
group and corresponding DNase-seq data was analyzed
after each was aligned by their TSS.
Gene density and TFBSs associated with DNaseI HS sites
The entire genome was scanned by 2 Mb windows. Within
each window, the number of genes, DNaseI HS sites,
CTCF binding sites, Pol2 and c-Myc binding sites were
quantitated. Linear regression was used to determine the
correlation between gene density and binding site density.
Enrichment/depletion of histone modiﬁcations at DNaseI
HS sites
To quantitatively measure histone modiﬁcation enrich-
ment or depletion at DNaseI HS sites, we evaluated the
histone signal based on the proﬁles of histone modiﬁcation
tag density by using the formula: Pi
DHSs, i ¼ 1,   ,10,
where P1
DHSs and P10
DHSs wee tag density at dxStart and
dxEnd, respectively. Enrichment or depletion of histone
modiﬁcations at DNaseI HS sites were deﬁned as
  ¼ð P5
DHSs+P6
DHSsÞ=ðP1
DHSs+P10
DHSsÞ, where  >1.0 indi-
cated enrichment and 0  <1.0 indicated depletion.
DNaseI HS sites associated with histone modiﬁcations and
expression levels
Cell type speciﬁc, common and ubiquitous DNaseI
HS sites were divided among 100 groups according to
DNaseI hypersensitivity. The average tag density of
DNaseI HS and of histone modiﬁcations was calculated
for each group.
The 17751 UCSC known genes with expression infor-
mation were divided into 100 groups, based on expression.
The average tag densities of each modiﬁcation and the
DNaseI HS within the gene body were calculated for
each group, respectively.
Motif identiﬁcation
To carry out motif identiﬁcation, we examined data of
DNaseI HS sites that encompassed deﬁned ChIP-
enriched regions in each cell line. CUDA-MEME
(Version 3.0) (33), which was programmed using hybrid
CUDA (Compute Uniﬁed Device Architecture) based on
MEME (Version 4.4.0) (34) was used to discover consen-
sus motifs with default parameters.
To determine the number of peaks that could be ex-
plained by statistically signiﬁcant motifs, the MEME
tool MAST (35) was used to estimate the maximal
difference between the total number of peaks containing
a motif and the number that could be explained by chance
within a range of stringencies (E-values). See Methods in
Supplementary Data for generation of MAST curves.
RESULTS
Global properties of DNaseI HS sites
Classiﬁcation of DNaseI HS sites. We classiﬁed DNaseI
HS sites according to their occurrence rates: cell type
speciﬁc, found in one out of 29 cell lines; common,
found in 2 to 28 cell lines or ubiquitous, found in all 29
cell lines (Supplementary Table S3).
In the erythroleukemia cell type K562, 9% of the
DNaseI HS sites were found to be cell type speciﬁc,
while the remaining 77% were common and 14% were
ubiquitous (Figure 1A). In the strongest DNaseI HS
sites (top 20%), 58% were found to be ubiquitous and
only 1% of them to be cell type-speciﬁc (Figure 1A). In
contrast, in the weakest DNaseI HS sites (bottom 20%),
we found that 19% were cell type-speciﬁc and almost none
were ubiquitous (Figure 1A). Similar observations were
obtained from other cell lines (Supplementary Figure
S2). Taken together, these ﬁndings indicated that ubiqui-
tous DNaseI HS sites are extremely hypersensitive to
DNaseI digestion, while cell type-speciﬁc DNaseI HS
sites are less susceptible to digestion, although still signiﬁ-
cantly more susceptible than the genome average. This is
expected since ubiquitous DNaseI HS sites are accessible
in all 29 cell types analyzed, and cell type-speciﬁc DNaseI
HS sites are only accessible in one cell type.
Genome-wide coverage of DNaseI HS sites represented. To
determine whether the majority of DNaseI HS sites that
exist in the human genome were represented in the data
sets under examination, we computed the cumulative per-
centage of the genome covered by DNaseI HS sites and
the cumulative numbers of DNaseI HS sites with respect
to the number of cell lines tested [Methods in
Supplementary Data; described in (26)]. Therefore, as add-
itional cell lines were included in the analysis, the total
number of DNaseI HS sites being investigated increased;
ultimately, we examined approximately 900000 DNaseI
HS sites from 29 cell lines (Figure 1B). Accordingly, the
total percentage of base pairs (bps) in the human genome
covered by DNaseI HS sites was calculated at 8.28%. A
total of 18 943 ubiquitous and 10100 cell type-speciﬁc
DNaseI HS sites were identiﬁed from the 29 cell types,
which covered 0.67 and 0.07% of bp in the human genome,
respectively. However, even after addition of the 29th cell
line we were unable to reach a signiﬁcant saturation level
of total DNaseI HS sites, which would have been repre-
sented by equal levels of cell type speciﬁc, common and
ubiquitous DNaseI HS sites. This ﬁnding was consistent
with previously published results using only six cell types
and examining 1% of the human genome (26), and sup-
ported the suggestion by those authors that substantially
more cell lines/types must be included in future analysis to
identify the majority of the DNaseI HS sites that exist in
the entire human genome.
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Figure 1. Identiﬁcation and characterization of DNaseI HS sites. (A) Genome-wide distribution of DHSs relative to cell type. Total numbers of cell
type speciﬁc, common and ubiquitous DHSs are indicated. The proportions of DHSs in the K562 cell line among the strongest scoring (top 20%)
and weakest scoring DHSs (bottom 20%) are shown. (B) Cumulative percentage of the genome and cumulative numbers covered by DNaseI HS sites
from increasing numbers of cell lines (x-axis). Cumulative percentage of the genome (solid lines) and numbers (dashed lines) covered by all (red), cell
type speciﬁc (green) and ubiquitous (blue) DNaseI HS sites from any cell line. Each point represents an averaged value of all possible cell line
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(continued)Genome-wide localization of DNaseI HS sites. To obtain
an overall picture of the DNaseI HS site distribution
pattern relative to genes, we divided the human genome
into four regions: proximal promoter, 1kb upstream and
downstream of the TSS; exon; intron and intergenic re-
gions. Groups were assigned based on the ‘GENCODE’
annotation published in the UCSC Genome Browser.
In the K562 cell line, only 14 and 9% of all DNaseI HS
sites mapped to proximal promoters and exons, respect-
ively, while 24% mapped to introns (Figure 1C). The
majority (53%) mapped within intergenic regions.
However, we discovered that over 20% of DNaseI HS
sites located within intergenic region, on average, are
associated with strong Pol II signals; this correlation
indicated these DNaseI HS sites may in fact represent a
promoter, exon or intron of an unannotated gene
(Supplementary Data and Supplementary Figure S3).
The genome-wide location results were well agreed with
previously published results in human islets (27) and
CD4
+ T cells (25). Of note, the DNaseI HS sites found
to be located within promoters and exons were over 2-fold
larger in size and twice as hypersensitive than those located
in the introns or intragenic regions (Supplementary
Table S4). When we considered only the cell type-speciﬁc
DNaseI HS sites, we found that  9% were located in
proximal promoters or exons. In stark contrast, nearly
one-half of the ubiquitous DNaseI HS sites were located
in proximal promoters or exons (Supplementary Table
S5). Similar distribution patterns were observed in other
cell lines (Supplementary Tables S4 and S5). These
ﬁndings, when considered along with the results from
our analysis of overlapping CpG islands and sequence
conservation within those sites (Supplementary Figures
S4 and S5; Methods in Supplementary Data), indicate
that ubiquitous DNaseI HS sites are generally associated
with promoters of so-called ‘housekeeping’ genes.
Gene density and binding sites associated with DNaseI HS
sites. To examine the correlation of DNaseI HS sites with
gene density in the surrounding regions and presence of
TFBSs, we segmented each chromosome into 2Mb
windows and counted the numbers of DNaseI HS sites
and genes and binding sites within each. In general, the
DNaseI HS sites were found to strongly correlate with
genes in all of the cell lines examined (R
2=0.9122 in
K562; Figure 1D). Additionally, the DNaseI HS sites
were highly correlated with Pol II in each cell line
(R
2=0.9553 in K562; Figure 1D). These results were con-
sistent with observations by others that the open chroma-
tin state is afﬁliated with gene dense regions in the genome
(36). Interestingly, we found that DNaseI HS sites cor-
related with TFBSs, as evidenced by analysis of the
CTCF and c-Myc binding sites (R
2=0.9052 and
R
2=0.9383, respectively; Figure 1D). This ﬁnding
conﬁrmed the Ling et al. (28) study for a larger set of
TFs that binding sites show up to 90% overlap with
DNaseI HS sites. The property of DNaseI HS site distri-
bution is consistent with its role at identiﬁcation of TFs
and suggests a widespread function of DNaseI HS sites in
the genome.
Genome-wide correlation of DNaseI HS sites and histone
modiﬁcations
Histone modiﬁcations near and in DNaseI HS sites. To
characterize the histone modiﬁcation patterns at DNaseI
HS sites, we aligned the DNaseI HS sites of each group
(cell type speciﬁc, common, ubiquitous) and com-
pared each with the histone modiﬁcations of that region.
Methylation and acetylation were examined, as distinct
forms of each have been associated with activation, re-
pression or both according to context. For example,
the H3K27me3 methylation modiﬁcation has been
reported as being present at sites of repressed a gene
expression (19).
As shown in Figure 2, all three states of H3K4 methy-
lation and acetylation of both H3K9 and H3K27 were
sharply elevated in different types of DNaseI HS sites.
H3K9me1 and H4K20me1 were modestly elevated in cell
type speciﬁc and common DNaseI HS sites, and the ele-
vated levels of these two marks were diminished in ubi-
quitous DNaseI HS sites (Figure 2). We did not observe
elevated levels of trimethylation of either H3K27 or
H3K36 in areas surrounding the DNaseI HS sites
(Figure 2). The tag densities of these histone modiﬁcations
in ubiquitous DNaseI HS sites were much higher than
those in cell type-speciﬁc DNaseI HS sites, except for
H3K4me1 and H3K27me3. The percentages of various
histone modiﬁcations overlapping with DNaseI HS sites
from each of the different types are shown in the inset of
Figure 2. Only a small fraction of the cell type-speciﬁc
DNaseI HS sites overlapped with H3K4me2, H3K4me3,
H3K9ac and H3K27ac; in contrast, about one-half of
cell type-speciﬁc DNaseI HS sites overlapped with
H3K4me1, H3K9me1, H3K27me3 and H4K20me1
(Figure 2A). Nearly 70% of the ubiquitous DNaseI HS
sites overlapped with all of the histone modiﬁcations
(Figure 2C), and of these, about one-fourth were located
in proximal promoters.
We next examined the enrichment/depletion of histone
modiﬁcation proﬁles at each type of the DNaseI HS sites.
We were intrigued to discover that both active and re-
pressive histone modiﬁcations corresponded to the deple-
tion at the peak signal of ubiquitous DNaseI HS sites,
albeit to differing extents (Figure 2 and Supplementary
Table S6). However, we did not observe similar modiﬁed
histone troughs for the cell type-speciﬁc DNaseI HS sites,
except in the cases of H3K9 and H3K27 acetylation
(Figure 2; Supplementary Table S6). This analysis
Figure 1. Continued
combinations. (C) The genome-wide distribution of DNaseI HS sites in proximal promoters (deﬁned as 1kb upstream and downstream of TSS),
exons, introns and intergenic regions. Total numbers of DHSs relative to gene annotations are shown for the representative K562 cell line. (D) The
densities of DNaseI HS sites and transcription factor binding sites on each chromosome. The points plotted on the x- and y-axes represent the
number of binding sites/2 Mbp and the number of DNaseI HS sites/2 Mb, respectively.
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Figure 2. Histone modiﬁcations proximal to the DNaseI HS sites in K562 cell type. Histone modiﬁcation proﬁles of cell type speciﬁc (A), common
(B) and ubiquitous (C) DNaseI HS sites. The tag density for modiﬁcations is shown across the DNaseI HS sites and extending 5kb upstream of the
dxStart and downstream of the dxEnd. Inset shows the percentage of DNaseI HS sites of each different type overlapping with histone modiﬁcations.
The numbers on the x-axis correspond to: 1, H3K4me1; 2, H3K4me2; 3, H3K4me3; 4, H3K9ac; 5, H3K9me1; 6, H3K27ac; 7, H3K27me3; 8,
H3K36me3; 9, H4K20me1. The vertical dashed line indicates the peak of DNaseI HS signal within each DNaseI HS site.
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(continued)provided supportive evidence that the DNaseI HS peaks
within ubiquitous DNaseI HS sites are nucleosome
depleted. Noticeably, we found that the enrichment/deple-
tion at DNaseI HS sites was strongly correlated with
the level of DNaseI HS (Supplementary Figure S6 and
Supplementary Table S7). Moreover, the correlation of
the enrichment/depletion at the ubiquitous DNaseI HS
sites was much stronger than that found at the cell
type-speciﬁc DNaseI HS sites. Trimethylation of H3K27
was the only outlier to this trend, suggesting that the
degree of nucleosome depletion is related to the level of
DNaseI HS.
Correlation between DNaseI HS and histone
modiﬁcations. To examine the correlation between
DNaseI HS sites and the different histone modiﬁcations
across the entire human genome, we separated cell type
speciﬁc, common and ubiquitous DNaseI HS sites into
100 groups for each, based on level of DNaseI hyper-
sensitivity. These groups were then plotted against
their average modiﬁcation levels in DNaseI HS sites
(Figure 3; see ‘Materials and Methods’ section).
For the cell type-speciﬁc DNaseI HS sites, we observed
a strongly negative correlation between H3K27me3
and DNaseI hypersensitivity, but a strongly positive cor-
relation between DNaseI hypersensitivity and all other
histone modiﬁcations (Figure 3A and Supplementary
Table S8). Similar correlations between histone modiﬁ-
cations and DNaseI hypersensitivity were found for
the common DNaseI HS sites, with the exception of a
weak correlation with H3K36me3 (Figure 3B and
Supplementary Table S8). In ubiquitous DNaseI HS
sites, however, modest positive correlations between
DNaseI hypersensitivity and H3K4me2, H3K4me3 and
H3K9ac were detected and a weak correlation was
found with H3K27ac (Figure 3C and Supplementary
Table S8). In this type of DNaseI HS sites, DNaseI hyper-
sensitivity was negatively correlated with H3K4me1,
H3K9me1, H3K27me3, H3K36me3 and H4K20me1; the
H3K36me3 was most negatively correlated, followed in
descending order by H4K20me1, H3K9me1, H3K27me3
and H3K4me1 (Figure 3C and Supplementary Table S8).
Genome-wide correlation of DNaseI HS sites and gene
expression
DNaseI HS proximal to TSSs. To identify the general dis-
tribution pattern of DNaseI HS sites near and around
TSSs, we generated composite proﬁles (n=1000 each)
of the 1000 most active, 1000 median and 1000 least
active genes. The genomic region that was analyzed en-
compassed the entire deﬁned gene body (exons and
introns) and extended 5kb upstream and 5kb downstream
of the 50- and 30-boundaries (Figure 4A). Numbers of tags
in the gene body were quantitated in windows representing
10 equal parts, and in the 50- and 30-proximal regions in
0.2kb windows; total numbers for each window were then
summed to obtain to the overall methylation level for each
Figure 2. Continued
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Figure 3. Correlation between DNaseI HS and histone modiﬁcations in K562 cell type. Cell type speciﬁc (A), common (B) and ubiquitous (C)
DNaseI HS sites were grouped among 100 sets (dot) based on their hypersensitive levels (from high to low, left to right on the x-axis). The average
tag density of DNaseI hypersensitive and of histone modiﬁcations was calculated for each group and plotted according to the average tag density of
DNaseI hypersensitive (right y-axis) and the histone methylation (left y-axis).
Nucleic Acids Research, 2011,Vol.39, No. 17 7435gene. These numbers were then normalized by the total
number of base pairs in each region. It was notable that
the DNaseI hypersensitivity signal peaked near both the
50- and 30-ends. As such, this signature may represent a
useful method by which to conﬁrm annotated TSSs, to
identify novel TSSs or to determine alternative TSSs func-
tioning in particular cell types (37). In addition, the
DNaseI hypersensitivity level of active genes was consist-
ently much higher than that of silent genes, suggesting that
DNaseI hypersensitivity is associated with transcriptional
activation.
We then examined the distribution of DNaseI HS sites
that overlapped these genes. As shown in the inset of
Figure 4A, 849 of the most active genes were found to
be associated with DNaseI HS sites, whereas only 421 of
the least active genes were similarly associated. Of those
most active genes, 258 (>30%) associated with ubiquitous
DNaseI HS sites, while only 22 ( 5%) of the most silent
genes associated with ubiquitous DNaseI HS sites.
Association with cell type-speciﬁc DNaseI HS sites was
found with 22% (189) of the most active genes and
>30% (148) of the most silent genes, respectively. These
results suggested that ubiquitous DNaseI HS sites are
associated with gene activation, whereas cell type-speciﬁc
DNaseI HS sites are associated with gene repression.
DNaseI HS and gene expression. To investigate whether
the DNaseI hypersensitivity level was correlated with gene
expression level, we grouped the genes into 100 gene sets
according to expression level. The sets were then plotted
against the DNaseI hypersensitivity levels in the
transcribed regions (Figure 4B). This analysis indicated
that a strong positive correlation exists between the level
of DNaseI hypersensitivity and gene expression
(R=0.8713, P=4.73E-32). We then used the same
method to assess the correlation of gene expression with
the level of DNaseI hypersensitivity within the different
types of DNaseI HS sites (Supplementary Figure S7), and
found that the positive correlation remained for each. Cell
type-speciﬁc DNaseI HS sites were more robustly
correlated with gene expression than were the ubiquitous
DNaseI HS sites, suggesting that cell type-speciﬁc DNaseI
HS sites are involved in cell type-speciﬁc gene regulation
(Supplementary Figure S7).
Four distinct modes of chromatin domains
DNaseI HS related to both histone modiﬁcations and gene
expression. To further clarify whether the relationship
between the DNaseI HS sites and histone modiﬁcations
correlates with gene expression, we compared the DNaseI
HS sites and histone modiﬁcations with gene expression
levels of 17 751 genes. We generated an image plot to
determine the average signals of active and repressive
histone modiﬁcations relative to the tag density of
DNaseI hypersensitivity and gene expression levels
(Materials in Supplementary Data). Trimethylation of
H3K4 and H3K27 were examined as representatives of
active and repressive histone modiﬁcations, respectively.
The results further conﬁrmed previous observations that
DNaseI hypersensitive signal is strongly positively
correlated with active histone modiﬁcations and inversely
correlated with repressive histone marks (Supplementary
Figure S8). The genes with higher levels of the H3K4me3
signal tended to be expressed at higher levels, while the
presence of H3K27me3 signals tended to correlate with
decreased levels of expression. This was also consistent
with previously published ﬁndings by others in which
gene expression was signiﬁcantly associated with
presence of histone modiﬁcations (7,19). The interrelated-
ness of DNaseI hypersensitivity, gene expression and
histone modiﬁcations indicated that active histone modi-
ﬁcations generally correlate with the open chromatin state
and active gene expression, whereas repressive histone
marks indicate closed chromatin and gene silencing
(Supplementary Figure S8).
H3K4me3 and H3K27me3 are referred to as a pair of
‘active-repressive’ modiﬁcations with regard to their
effects on gene activity (7). The overlapping islands of
H3K4me3 (‘active’) and H3K27me3 (‘repressive’) histone
modiﬁcations are deﬁned as ‘bivalent domains’, which
have been implicated in the development and differenti-
ation of mammalian embryonic stem cells and
differentiated cells (7,21,22,38–41). By counting the total
numbers of H3K4me3 and H3K27me3 modiﬁcations
within each of the different types of DNaseI HS sites
from the K562 cell line, we determined that, 15 and
45% of all DNaseI HS sites were associated with
H3K4me3 and H3K27me3, respectively (Figure 5A).
These numbers were consistent with other cell lines
examined (Supplementary Figure S9). Intriguingly,
>10% of all DNaseI HS sites were associated with both
H3K4me3 and H3K27me3 modiﬁcations in multiple cell
lines of different origins (Figure 5A and Supplementary
Figure S9), indicating that bivalent domains are a wide-
spread phenomenon in mammalian cells and suggesting
that the ‘active-repressive’ switch is functionally relevant.
However, recent studies suggested that bivalent marks, as
described for mammalian embryonic stem cells, do not
exist in Xenopus embryos (42,43). Future studies in differ-
ent model organisms at various developmental stages are
essential to elucidate the curious case of the occurrence or
absence of bivalent marks (43).
Examining the composition of these DNaseI HS sites
showed that over one-third of those with H3K4me3 alone
or with both 3K4me3 and H3K27me3 were of the ubiqui-
tous type (Figure 5A and Supplementary Figure S10).
However, only 7% of the DNaseI HS sites overlapping
with either H3K4me3 alone, both 3K4me3 and
H3K27me3 or H3K27me3 alone, were of the cell type-
speciﬁc type (Figure 5A and Supplementary Figure S10).
We then sought to determine whether the signals of
DNaseI hypersensitivity, gene expression and H3K4me3
and H3K27me3 signiﬁcantly differed among the DNaseI
HS sites that were associated with H3K4me3 alone, both
H3K4me3 and H3K27me3 or H3K27me3 alone, or not
associated with H3K4me3 or H3K27me3 at all. As
shown in Figure 5B, the highest levels of gene expression,
DNaseI hypersensitivity and H3K4me3, and the lowest
levels of H3K27me3 were associated with DNaseI HS
sites that overlapped with H3K4me3 alone. The lowest
levels of gene expression, DNaseI hypersensitivity and
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Figure 4. Correlation between DNaseI HS and gene expression in K562 cell type. (A) Proﬁles of DNaseI HS sites across the gene bodies of the most
active, median or most silent genes (n=1000 each group). Inset shows the percentage of DNaseI HS sites of each different type that composed the
three gene groups. The numbers on the x-axis correspond to: 1, cell type speciﬁc; 2, common; 3, ubiquitous. (B) DNaseI HS sites were grouped into
100-gene sets (dot) based on their expression levels (high to low, left to right on the x-axis). The average tag densities of the DNaseI HS within the
gene body and the average gene expression level were calculated for each group and plotted according to the average gene expression level (left
y-axis) and the average tag density of DNaseI hypersensitive (right y-axis).
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Figure 5. Four distinct modes of function for chromatin domains. (A) The percentage of DNaseI HS sites associated with H3K4me3 alone, both
H3K4me3 and H3K27me3 or H3K27me3 alone, or not associated with H3K4me3 or H3K27me3 in K562 cells. The bar indicates the composition of
those DNaseI HS sites that overlapped with both H3K4me3 and H3K27me3. (B) Distribution of DNaseI HS, gene expression, H3K4me3 and
H3K27me3 signal at DNaseI HS sites associated with H3K4me3 alone, both H3K4me3 and H3K27me3 or H3K27me3 alone, or not associated with
H3K4me3 or H3K27me3 in K 562 cells. (C) Four distinct modes of chromatin domains. Region I, active chromatin domains; Region II, silent
chromatin domains; Region III, bivalent chromatin domains; Region IV, primed chromatin domains.
7438 Nucleic Acids Research, 2011,Vol.39, No. 17H3K4me3, and the highest levels of H3K27me3 were
associated with DNaseI HS sites that overlapped with
H3K27me3 alone. The DNaseI HS sites that overlapped
with both H3K4me3 and H3K27me3 were characterized
by high levels of gene expression, DNaseI hypersensitivity,
and H3K4me3 and H3K27me3.
Four distinct functions of chromatin structure. Based on
the relationship of DNaseI hypersensitivity with active
and repressive histone modiﬁcations and gene expression,
we theorized that at least four major functional modes
existed for the different chromatin domain structures
observed in the human genome across different cell
types (Figure 5C). (i) Active chromatin domains were
characterized by relatively higher levels of active histone
modiﬁcations, DNaseI hypersensitivity and gene expres-
sion, and lower levels of repressive histone modiﬁcations
(Figure 5B; Region I in Figure 5C), (ii) Silent chromatin
domains were characterized by lower levels of active
histone modiﬁcations, DNaseI hypersensitivity and gene
expression and higher levels of repressive histone modiﬁ-
cations (Figure 5B; Region II in Figure 5C), (iii) The
bivalent chromatin domains were characterized by high
levels of both active and repressive histone modiﬁca-
tions, and high levels of DNaseI HS and gene expression
(Figure 5B; Region III in Figure 5C) and (iv) The primed
chromatin domains are characterized by patterns of active
histone modiﬁcations and gene expression similar to the
active chromatin domains, but also have similar patterns
to the repressive chromatin domains of repressive histone
modiﬁcations and DNaseI hypersensitivity (Figure 5B;
Region IV in Figure 5C).
Identiﬁcation of CTCF binding sites
Next, we investigated whether the speciﬁc correlation
pattern between the data from DNase-seq and ChIP-seq,
in combination with gene expression from microarray
analysis, could be used to predict transcription factor
binding sites (TFBSs) in the human genome.
In vertebrates, the CTCF, a ubiquitously expressed 11
zinc ﬁnger (ZF) protein (44,45), is necessary for insulator
element function (46–48). To characterize how the CTCF
binding sites are distributed along the human genome, we
performed computational meta-analysis of the DNase-seq
and ChIP-seq data to identify potential CTCF binding
sites. We examined the DNaseI HS sites associated
with CTCF ChIP-enriched regions across cell lines
(Supplementary Table S9). Of the 35307 DNaseI HS
sites that overlapped with CTCF enriched regions in cell
type K562, 13 007 were distal (>1kb) to an annotated TSS
or RNA Pol II signal. Then, we applied the de novo motif
ﬁnder MEME to identify CTCF binding sites within these
13 007 distal DNaseI HS sites.
Our MEME analysis revealed that the CTCF consensus
DNA binding motif was enriched in these DNaseI HS
sites (Figure 6A). Furthermore, the consensus motif was
identical in each of the cell types studied (Supplementary
Figure S11) and was consistent with previous ﬁndings
from other cell lines (human islets, CD4
+ T cells, HeLa
cells and Jurkat cells) (27,49). Most of the distal DNaseI
HS sites (10397 out of 13007, 79.9%) contained at least
one consensus motif (Figure 6B). Of those, 149 (1.4%)
were cell type speciﬁc, whereas 7969 (76.7%) and 2279
(21.9%) were common and ubiquitous, respectively. This
agreed well with previous observations that CTCF
binding in insulator regions is similar across diverse cell
types (50). In a statistical context, the consensus motif
explains 65% (8456 out of 13007) of the distal DNaseI
HS sites after accounting for motifs that are expected
to occur by chance. Compared to using DNaseI-Seq
data (29%, 39951 out of 139121; Supplementary
Figure S12A) or ChIP-seq data (57%, 46328 out of
81688; Supplementary Figure S12B) alone, our result
illustrated the high accuracy of CTCF binding sites dis-
covery based on the integrative data (Figure 6B). Most
often, these distal DNaseI HS sites contained only a
single motif (Figure 6C).
The canonical motif was highly located on the peak of
the DNaseI HS signal within each DNaseI HS site
(Supplementary Figure S13A), which was consist with
previous ﬁnding (27). This indicated that these peaks
serve as the point of contact by the protein in vivo. Not
surprisingly, we also found that the identiﬁed motif is
located far distally from the nearest upstream or down-
stream associated genes (Supplementary Figure S13B), a
ﬁnding that would explain the widespread and fundamen-
tal role of CTCF. Although the identiﬁed motif appeared
to represent the major CTCF binding sequence, a signiﬁ-
cant number of the sites lacked the consensus sequence.
Another study recently found that CTCF can bind to
genomic regions that apparently lack the deﬁned motif
(51); this may be a result of DNA–CTCF interactions
mediated by contacts with distinct arrangements of
CTCF’s 11-ZFs (44,48,52–54).
DISCUSSION AND CONCLUSION
Global properties of DNaseI HS sites
The dynamic and complex regulatory elements of gene
transcription that underlie every biological process, from
cell type-speciﬁc functions to systemic response to the en-
vironment, remain to be completely deﬁned or under-
stood. Whole-genome mapping of DNaseI HS sites has
provided crucial clues to regions of transcriptional regu-
lation. By combining these data with data from ChIP-seq
and gene expression microarray experiments, we may gain
a better understanding of this process. To this end, we
performed a meta-analysis using each of these datasets
that are publically available. By classifying the DNaseI
HS sites according to their characteristic of cell type
speciﬁc, common or ubiquitous, we were able to identify
approximately 900000 DNaseI HS sites from 29 diverse
cell lines. These sites of presumed transcriptional regula-
tory function encompassed 8.28% of the human genome,
which was in agreement with the proportion reported in a
related study (26). Detailed examination of all the DNaseI
HS sites in each of the 29 cell lines revealed that only
approximately 10000 ( 7%) are cell type speciﬁc and ap-
proximately 19000 ( 14%) were ubiquitous, covering
0.67 and 0.07% of the human genome, respectively.
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Figure 6. Motif analysis of DNaseI HS sites. (A) Signiﬁcantly enriched CTCF consensus motifs are graphically depicted using Weblogos. (B) MAST
curves. Horizontal axis represents the E-value, the number of peaks expected to contain a given motif by chance. The vertical axis represents
the number of peaks identiﬁed. The red curve (peaks with motifs) represents the number of peaks containing a given motif at the corresponding
E-value. The blue curve (peaks explained) represents the number of peaks that contained a motif not by chance. The maximum of the peaks
explained curve is displayed. (C) The histograms of the distribution of the motif number within the distal DNaseI HS sites that overlapped with
CTCF binding sites.
7440 Nucleic Acids Research, 2011,Vol.39, No. 17The percentage of cell type-speciﬁc DNaseI HS sites was
much smaller than that obtained previously by Xi et al.
(26). This discrepancy may be due to the particular cell
types examined in our study or the fact that we examined
more different cell types in total. Nonetheless, even
though 29 cell types were considered in our study, we
were also unable to reach the statistical saturation point
for the DNaseI HS sites that are likely to exist throughout
the human genome. This ﬁnding indicated that functional
TFBSs make up a more signiﬁcant percentage of the
genome.
By investigating the ubiquitous DNaseI HS sites, we
hoped to gain insight into the function of housekeeping
genes and overall chromatin structures. Our location
analysis of DNaseI HS sites relative to annotated genes
indicated that nearly 50% of the ubiquitous DNaseI HS
sites in these data sets were located in proximal promoters
or exons. This analysis, when considered in tandem with
the overlapping with CpG islands between DNaseI HS
sites and levels of sequence conservation among different
cell lines (Supplementary Figures S4 and S5), indicated
that ubiquitous DNaseI HS sites are generally associated
with housekeeping promoters of genes. The strong correl-
ation of DNaseI HS sites with TFBSs revealed that
DNaseI HS sites are highly restricted to gene regions and
their transcriptional regulatory elements. This provides
further proof that DNaseI HS sites in the genome are
valuable markers of TF binding regions.
Correlations among DNaseI HS, histone modiﬁcations
and gene expression
Other groups have noticed sharp declines in the presence
of active histone marks near TSSs, termed as nucleosome
depleted regions (7,25,55). Interestingly, we observed that
both active and repressive histone modiﬁcations are char-
acterized by modiﬁed histone troughs, which are centered
at DNaseI HS peaks of ubiquitous DNaseI HS sites, sug-
gesting that these regions are nucleosome depleted. The
degree of nucleosome depletion is undoubtedly related to
chromatin accessibility and level of DNaseI hypersensitiv-
ity (Supplementary Figure S6; Supplementary Table S7).
Our ﬁnding extends previous observations made in yeast,
ﬂies and mammalian systems, particularly the human, that
nucleosome depletion is a general characteristic of active
promoters. Furthermore, our ﬁnding provides supportive
evidence that nucleosome depletion is associated with ubi-
quitous DNaseI HS sites and the ubiquitous DNaseI HS
sites are nucleosome depleted.
Both cell type speciﬁc and ubiquitous DNaseI HS sites
are generally positively correlated with active histone
modiﬁcations H3K4me2/3, H3K9ac, H3K27ac and nega-
tively correlated with the repressive modiﬁcation
H3K27me3. Interestingly, monomethylations of H3K4,
H3K9, H3K36 and H4K20 display a more complex func-
tional relationship with chromatin, as they are positively
correlated with cell type-speciﬁc DNaseI HS sites and
negatively correlated with ubiquitous sites. Correlation
of DNaseI hypersensitivity with gene expression suggests
that DNaseI hypersensitivity is highly correlated with
transcriptional activation. Ubiquitous DNaseI HS sites
were associated with active genes, while cell type-speciﬁc
DNaseI HS sites were correlated with silent genes.
Correlations of DNaseI hypersensitivity, histone modiﬁ-
cations and gene expression indicated that active histone
modiﬁcations generally correlated with active gene expres-
sion and the open (accessible) chromatin state, whereas
repressive histone marks correlated with gene silencing and
tightly packed (inaccessible) chromatin state (Figure 5C).
These speciﬁc correlations were summarized to reveal four
distinct modes of chromatin domain function: repressive,
active, primed and bivalent. These modes of association,
which are much more ﬁnely described than the traditional
classiﬁcation of heterochromatin (open) or euchromatin
(closed), provide insights into the complex structure and
function of chromatin.
Identiﬁcation of regulatory elements via an integrative
approach
After systematic exploration of the relationships between
data emanating from DNase-seq, ChIP-seq and gene ex-
pression microarrays, we were able to identify transcrip-
tional regulatory elements by using the de novo motif
ﬁnder MEME. Our limited MEME analysis of the CTCF
binding sites served to illustrate the high speciﬁcity and
accuracy in identiﬁcation of transcriptional regula-
tory elements using the integrated data sets (Figure 6B
and Supplementary Figure S12). The advent of high-
throughput methods, including DNase-chip/DNase-seq,
ChIP-chip/ChIP-seq and gene expression arrays, has en-
couraged large storage databases of related data and pub-
lic availability for more signiﬁcant analysis. Combining
distinct genome scale data in meta-analysis approaches
represents the next era of genomic research.
Our integrative analysis presented herein can be con-
sidered as ﬁrst-order data integration. The simplicity of the
overlapping approach to determine regions and character-
istics of enriched domains from DNase-seq and ChIP-seq
data, along with the motif discovery and Gene Ontology
strategies, represent an efﬁcient means by which to
perform integrative analysis. The next higher order, com-
prehensive, integrative analysis should integrate diverse
high-throughput sequence tags directly. Additionally,
interactome data (56) can be applied to facilitate identiﬁ-
cation of the target genes of DNaseI HS sites, since TFs
and their three-dimensional interactions are crucial to
gene regulation (57,58). Technologies based on chromo-
some conformation capture (3C) (59), circularized
chromosome conﬁrmation capture (4C) (60), carboncopy
chromosome conﬁrmation capture (5C) (61) and the
recently developed methods of Hi-C (62) and chromatin
interaction analysis by paired-end tag sequencing
(ChIA-PET) (63,64), can be used to provide a high-
resolution genome-wide map of long-range genomic inter-
actions. Integrating a wide variety of genomic data sets,
including genomes, epigenomes (55), transcriptomes (65)
and interactomes (56) will signiﬁcantly enhance our under-
standing of the complex genomic systems of all life forms
and enhance our efforts to understand and modulate
health and optimize well-being (66).
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